Standardized serum 25-hydroxyvitamin D concentrations are inversely associated with cardiometabolic disease in U.S. adults: a cross-sectional analysis of NHANES, 2001–2010

Abstract

BackgroundPreviously reported associations between vitamin D status, as measured by serum 25-hydroxyvitamin D [25(OH)D] concentrations, and cardiometabolic risk factors were largely limited by variability in 25(OH)D assay performance. In accordance with the Vitamin D Standardization Program, serum 25(OH)D measurement was recently standardized in the National Health and Nutrition Examination Survey (NHANES) to reduce laboratory and method related differences in serum 25(OH)D results. We evaluated the overall and ethnic-specific associations between the newly standardized serum 25(OH)D concentrations and cardiometabolic risk in U.S. adults.MethodsThis study examined standardized 25(OH)D data from five cycles of the NHANES (2001–2010). The total sample included 7674 participants (1794 Mexican-Americans, 4289 non-Hispanic whites, and 1591 non-Hispanic blacks) aged ≥ 20 years who were examined in the morning after overnight fasting. Serum 25(OH)D was directly measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS) in 2007–2010, and was predicted from LC-MS/MS equivalents for 2001–2006. Serum 25(OH)D levels were categorized into quartiles (<43.4, 43.4–58.6, 58.7–74.2, ≥74.3 nmol/L). Cardiometabolic risk was defined by the homeostatic model assessment of insulin resistance (HOMA-IR), metabolic syndrome (MetS), and Framingham cardiovascular disease (CVD) risk. Prevalence ratios and 95% confidence intervals were calculated using modified Poisson regression.ResultsAfter full adjustment for confounders, serum 25(OH)D ≥74.3 nmol/L was associated with lower cardiometabolic risk compared to 25(OH)D <43.4 nmol/L in the overall sample [HOMA-IR: 0.70 (0.59, 0.84); MetS: 0.82 (0.74, 0.91); CVD risk: 0.78 (0.66, 0.91)]. These associations remained significant in Mexican-Americans [HOMA-IR: 0.54 (0.35, 0.82); MetS: 0.73 (0.55, 0.96)], non-Hispanic whites [HOMA-IR: 0.81 (0.68, 0.96); MetS: 0.84 (0.73, 0.95); CVD risk: 0.78 (0.64, 0.93)]; and in non-Hispanic blacks [HOMA-IR: 0.67 (0.45, 0.99); MetS: 0.75 (0.56, 0.97); CVD risk: 0.58 (0.41, 0.81)].ConclusionsLow vitamin D status is a significant risk factor for cardiometabolic disease in U.S. adults based on standardized serum 25(OH)D results, irrespective of ethnic background. Future studies using standardized 25(OH)D data are needed to confirm these results, particularly amongst U.S. blacks with 25(OH)D concentrations above 75 nmol/L.

Low-Calorie Beverage Consumption, Diet Quality and Cardiometabolic Risk Factors in British Adults

“…In contrast, a recent review [ 28 ] including 372 studies (15 systematic reviews, 155 randomised controlled trials, 23 non-randomised controlled trials, 57 cohort studies, 52 case-control studies, 28 cross sectional studies, 42 case series/case reports) found that in healthy subjects, there was no conclusive evidence for the harmful effects of low-calorie sweeteners. In subjects with diabetes and hypertension, the evidence regarding the health outcomes of low-calorie sweeteners was also found to be inconsistent.…”

“…Given the cross-sectional nature of the NDNS survey, we cannot rule out reverse causality for some of the study outcomes, such as obesity and other cardiometabolic indices [ 12 , 28 ]. However, randomised trials within this area are also limited by the short or medium-term evaluation of interventions [ 19 ].…”

Association of Vitamin D Deficiency and Degree of Coronary Artery Disease in Cardiac Patients with Type 2 Diabetes

“…Participants in our study were examined throughout the whole year on what may influence their 25(OH)D level. Examination data corresponds to the season of blood draw, which was reported by NHANES as winter months (November to April) and summer months (May to October) [ 44 ]. In all patients, determination of 25(OH)D was performed before coronary angiography.…”

Vitamin D deficiency and insufficiency among US adults: prevalence, predictors and clinical implications

“…We removed missing measurements from the study for two considerations: (1) the included data without missing values were quite large and could ensure the analysis power to detect the significance difference; and (2) excluded missing values could be reasonably thought to have no significant impact on the final results because there were no significant differences in characteristics between included data and excluded missing data. (34,35) . The total concentrations of serum 25 (34) .…”